Fifth Third Bancorp Myriad Genetics Inc Transaction History

Fifth Third Bancorp

  • $28.3 Billion
  • Q2 2025

A detailed history of Fifth Third Bancorp transactions in Myriad Genetics Inc stock. As of the latest transaction made, Fifth Third Bancorp holds 2,267 shares of MYGN stock, worth $18,272. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,267
Previous 46,489 95.12%
Holding current value
$18,272
Previous $412,000 97.09%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 15, 2025
SELL
$3.84 - $8.84 $169,812 - $390,922
-44,222 Reduced 95.12%
2,267 $12,000
Q1 2025

Apr 15, 2025
SELL
$8.87 - $14.98 $78,286 - $132,213
-8,826 Reduced 15.96%
46,489 $412,000
Q4 2024

Jan 21, 2025
SELL
$13.17 - $27.03 $306,808 - $629,690
-23,296 Reduced 29.63%
55,315 $758,000
Q3 2024

Oct 17, 2024
SELL
$23.97 - $28.6 $75,337 - $89,889
-3,143 Reduced 3.84%
78,611 $2.15 Million
Q2 2024

Jul 22, 2024
BUY
$17.98 - $25.47 $20,479 - $29,010
1,139 Added 1.41%
81,754 $2 Million
Q1 2024

Apr 23, 2024
BUY
$17.59 - $23.59 $49,463 - $66,335
2,812 Added 3.61%
80,615 $1.72 Million
Q4 2023

Jan 19, 2024
BUY
$13.91 - $21.32 $51,397 - $78,777
3,695 Added 4.99%
77,803 $1.49 Million
Q3 2023

Oct 31, 2023
SELL
$15.99 - $23.22 $6,172 - $8,962
-386 Reduced 0.52%
74,108 $1.19 Million
Q2 2023

Jul 25, 2023
BUY
$17.56 - $23.76 $93,489 - $126,498
5,324 Added 7.7%
74,494 $1.73 Million
Q1 2023

Apr 24, 2023
BUY
$15.26 - $23.75 $43,262 - $67,331
2,835 Added 4.27%
69,170 $1.61 Million
Q4 2022

Jan 25, 2023
BUY
$14.51 - $20.99 $113,685 - $164,456
7,835 Added 13.39%
66,335 $0
Q3 2022

Oct 25, 2022
BUY
$18.21 - $27.88 $610,745 - $935,067
33,539 Added 134.37%
58,500 $1.12 Million
Q2 2022

Aug 04, 2022
BUY
$16.45 - $25.88 $51,685 - $81,314
3,142 Added 14.4%
24,961 $454,000
Q1 2022

Apr 19, 2022
BUY
$22.67 - $28.01 $108,702 - $134,307
4,795 Added 28.17%
21,819 $550,000
Q4 2021

Feb 01, 2022
BUY
$24.13 - $32.63 $73,741 - $99,717
3,056 Added 21.88%
17,024 $470,000
Q3 2021

Oct 15, 2021
BUY
$29.97 - $36.66 $87,182 - $106,643
2,909 Added 26.3%
13,968 $451,000
Q2 2021

Aug 06, 2021
SELL
$25.39 - $32.61 $39,481 - $50,708
-1,555 Reduced 12.33%
11,059 $338,000
Q1 2021

May 07, 2021
BUY
$19.92 - $31.6 $19,661 - $31,189
987 Added 8.49%
12,614 $384,000
Q4 2020

Feb 16, 2021
BUY
$12.16 - $19.77 $52,312 - $85,050
4,302 Added 58.73%
11,627 $230,000
Q3 2020

Nov 09, 2020
BUY
$11.25 - $14.75 $3,318 - $4,351
295 Added 4.2%
7,325 $96,000
Q2 2020

Aug 05, 2020
BUY
$10.69 - $16.49 $39,713 - $61,260
3,715 Added 112.07%
7,030 $80,000
Q1 2020

May 05, 2020
BUY
$9.78 - $29.53 $32,420 - $97,891
3,315 New
3,315 $47,000

Others Institutions Holding MYGN

# of Institutions
234
Shares Held
94.2M
Call Options Held
460K
Put Options Held
14.2K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $650M
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email